Plné znění - 278/2014 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2015

278/2014 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

278

XXXXXXX

Xxxxxxxxxxxx xxxxxxxxxxxxx

xx xxx 20. xxxxxxxxx 2014

x xxxxxxxxxx xxxxxxx očkovacích xxxxx pro xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx xxx xxx 2015

Xxxxxxxxxxxx zdravotnictví xxxxx §80 odst. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx a o xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx xxx xxx 2015:

1. Xxxxxxxxx složení xxxxxxxxxx látek xxx xxxxxxxxxx xxxxxxxx

1x) kombinovaná xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx přenosné xxxxx (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx X, nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX):

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxx haemagglutinum xxxxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx

Xxxxxx xxxxxxxxxx min.

Antigenum xxxxxxxxx hepatitidis X xxxxxxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1

Xxxxx poliomyelitidis xxxxxxxxxxx xxxxx 2

Virus xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3

Xxxxxxxxxx Xxx: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Tetani xxxxxxxxxx

XXXX

1xx) xxxxxxxxxxx očkovací xxxxx xxxxx xxxxxxx, dávivému xxxxx (acelulární forma), xxxxxx, dětské xxxxxxxx xxxxx (inaktivovaná forma), xxxxxx xxxxxxxxxx B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ x ( XXxXXxxXXXXXX)

Xxxxxxxxxxx xxxxxxxxxx

Xxxxxx xxxxxxxxxx

Xxxxxxxx Xxxxxxxxxx xxxxxxxxx

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxxxxxxx xxxxxxxxxxxx

Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)

xxxxx 1 (Xxxxxxx)

xxxxx 2 (XXX-1)

xxxxx 3 (Xxxxxxx)

Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X

Xxxxxxxxxxx xxxxxxxxxx typu x xxxxxxxxxxxxxxx

(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)

xxxxxxxxx xxx xxxxxx xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx (XXxX):

Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx&xxxx;≥ 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 mikrogramů

Pertactinum (69xX) 8 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx b (XXxXXxx):

Xxxxxxxxxxx xxxxxxxxxx ........................................... xxx. 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx .................................................... min. 40 xxxxxxxxxxxxx jednotek

Pertussis xxxxxxxxxx (PT) ...................................... 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (FHA) .... 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) ................................................... 8 mikrogramů

Haemophilus xxxxxxxxxx B ....................................... 10 xxxxxxxxxx

xxx anatoxino xxxxxxxx ............................................ 20-40 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx typ x:

1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (přibližně 25 xxxxxxxxxx).

1x) očkovací látka xxxxx xxxxxx:

Xxxxxx xxxxxxxxxx ................................................... xxx. 40 xxxxxxxxxxxxx xxxxxxxx

1x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx 15 xxx xxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X .......................... 10 mikrogramů

1g) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx 16 xxx x výše:

Antigenum tegiminis xxxxxxxxxxx B ........................... 20 xxxxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx a zarděnkám:

Morbillorum xxxxx attenuatum (Xxxxxxx) xxx. 10^3,0 infekční xxxxx pro buněčnou xxxxxxx₅₀

Xxxxxxxxxxx virus xxxxxxxxxx (XXX 4385) min. 10^3,7 infekční xxxxx xxx xxxxxxxx xxxxxxx₅₀

Xxxxxxxx xxxxx xxxxxxxxxx (Wistar XX 27/3) xxx. 10^3,0 infekční xxxxx xxx xxxxxxxx xxxxxxx₅₀

1xx) xxxxxxxx xxxxx xxxxx xxxxxx přenosné obrně x xxxxxxxxxxxx xxxxx:

Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 1 (Mahoney) ........... 40 xxxxxxxxxxx D xxxxxxxx*

Xxxxx poliomyelitis inactivatum xxxxx 2 (XXX-1) ................ 8 xxxxxxxxxxx X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ............. 32 xxxxxxxxxxx X xxxxxxxx*

* xxxx množství xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.

1x) xxxxxxxx xxxxx proti xxxxxxx vyvolaným Xxxxxxxxxxxxx xxxxxxxxxx v xxxxxxxxxxxxxxx xxxxxxx:

Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6X, 7X, 8, 9N, 9X, 10X, 11 X, 12X, 14, 15X, 17X, 18X, 19X, 19X, 20, 22X, 23X, 33X ...... 25 mikrogramů x každého xxxxxxxx

1x) xxxxxxxx látka konjugovaná xxxxx pneumokokovým xxxxxxxx:

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 3

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 4

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 7X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 9X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 14

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18C

Pneumococcale xxxxxxxxxxxxxxx sérotypus 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23F

1ka) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxxx anatoxinum ............................... ne xxxx xxx 2 xxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx ........................................ xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx anatoxinum................................... 8 xxxxxxxxxx

Xxxxxxxxx haemagglutinum filamentosum ... 8 xxxxxxxxxx

Xxxxxxxxx ...................................................... 2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:

xxxxx 1 (xxxx Xxxxxxx) .............................. 40 D jednotek xxxxxxxx

xxxxx 2 (xxxx XXX-1) ................................... 8 X xxxxxxxx xxxxxxxx

xxxxx 3 (kmen Xxxxxxx) ................................ 32 X xxxxxxxx antigenu

NEBO

1kb) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxx xxxxxx ....................................... xxxx nebo xxxxx 2 mezinárodní jednotky (2 Xx)

Xxxxxxxxx xxxxxx ....................................... více xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx)

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx toxoid ................................ 2,5 xxxxxxxxxx

Xxxxxxxxxxxx xxxxxxxxxxxx ................. 5 xxxxxxxxxx

Xxxxxxx xxxx 2+3 ................................ 5 xxxxxxxxxx

Xxxxxxxxx ............................................. 3 mikrogramy

Virus poliomyelitis xxxx 1 (xxxxxxxxxxxx) ... 40 antigenních X xxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 2 (inaktivovaný) ... 8 xxxxxxxxxxx X jednotek

Virus poliomyelitis xxxx 3 (xxxxxxxxxxxx) ... 32 xxxxxxxxxxx X xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx tuberkulóze:

Mycobacterium xxxxx attenautum (XXX) xxxxxxx Danisuc 1331 ... 0,75 mg ≥ 2,0 x 10⁶ ≤ 8,0 x 10⁶ XXX (xxxxxx xxxxxxx)

1x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X xxx osoby xxxxxxxx xx dialyzačního xxxxxxxx:

Xxxxxxxxx xxxxxxxxx hepatitidis X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx AS04C xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx x 1 dávce

2. Xxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxx xxxxxxxx

2x) xxxxxxxx látka xxxxx virové xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:

Xxxxxxxxx tegiminis xxxxxxxxxxx X 20 xxxxxxxxxx

2x) xxxxxxxx látka xxxxx vzteklině

Virus xxxxxx xxxxxxxxxxx (xxxx Wistar xxxxxx XX/XX 38 1503-3M xxxx xxxx xxxxx 2,5 mezinárodních jednotek x 1 xxxxx (0,5 xx)

2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:

Xxxxxxxxx X xxxxx xxxxxxxxxxx

3. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx mimořádná xxxxxxxx

3x) očkovací xxxxx xxxxx xxxxxx hepatitidě X xx xxxxxxx xxx dospělé:

Hepatitis X xxxxx inactivatum

3b) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx A xx xxxxxxx pro xxxx:

Xxxxx xxxxxxxxx A xxxxxxxxxxx

X xxxx 2015 x xxxxxxx xx xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x očkování xxxxx xxxxxxxxx xxxxxxx, xxxxx xxxxxxxx xxxxxxxxx úpravu xxxxxxxxxxx složení očkovacích xxxxx xxx pravidelná xxxxxxxx publikováním xxxxxx xxxxxxxxxxx složení xxxxxx xxxxxxxxxx xxxxx xx Xxxxxx xxxxxx.

Xxxxxxx:

XXXx. Němeček, XXX, x. x.

Xxxxxxxxx

Xxxxxx předpis č. 278/2014 Xx. xxxxx xxxxxxxxx dnem 13.12.2014.

Ke xxx uzávěrky právní xxxxxxx xxxxx měněn xx doplňován.

Znění xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.